A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis

NCT05923099 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

262

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: LEO 138559
DRUG: Placebo

Sponsor

LEO Pharma